Detecting Cardiovascular
 Disease risk early so it can
be prevented

Detecting Cardiovascular
 Disease risk early so it can be prevented

NHS Partnership Accelerates Genetic Testing for CVD Prevention

In partnership with NHS North of England and Health Innovation North-East and North Cumbria, GENinCode is providing globally leading genetic testing to prevent CVD at reduced cost with improved turnaround time for the NHS.

NHS Partnership Accelerates Genetic Testing for CVD Prevention

In partnership with NHS North of England and Health Innovation North-East and North Cumbria, GENinCode is providing globally leading genetic testing to prevent CVD at reduced cost with improved turnaround time for the NHS.

Who we are

GENinCode specialises in risk assessment and prediction of cardiovascular disease and familial hypercholesterolemia.

Our Products
and Technology

GENinCode test products have been developed to help physicians make improved clinical decisions.
By delivering comprehensive risk assessment we are able to stratify patients and identify the most appropriate treatment pathways aligned with clinical guidelines to ensure optimal outcome.

Accreditation

Contact Us

UK

GENinCode UK Limited

Oxford Science Park,
John Eccles House
Robert Robinson Avenue
Oxford, OX4 4GP

+44 (0)1865 676 125
info@genincode.com

Spain

GENinCode S.L.U.
Rambla Egara, 235,
ES- 08224
Terrassa-Barcelona

+34 936 690 321
 info@genincode.com

US

GEN inCode U.S. Inc.
5 Mason, Suite 200
Irvine, CA 92618

+1 (949) 930-0462
info-us@genincode.com

Recent News